Aclaris Therapeutics (ACRS) FCF Margin Growth (3y) (2020 - 2026)
Aclaris Therapeutics (ACRS) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | -10,159.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,159.00 |
| Mar 31, 2026 | 13,179.00 |
| Dec 31, 2025 | -78,121.00 |
| Sep 30, 2025 | -28,791.00 |
| Jun 30, 2025 | 73,915.00 |
| Mar 31, 2025 | 55,045.00 |
| Dec 31, 2024 | 105,386.00 |
| Sep 30, 2024 | 114,889.00 |
| Jun 30, 2024 | 22,504.00 |
| Mar 31, 2024 | -18,529.00 |
| Dec 31, 2023 | 51,729.00 |
| Sep 30, 2023 | 59,512.00 |
| Jun 30, 2023 | -59,425.00 |
| Mar 31, 2023 | -55,160.00 |
| Dec 31, 2022 | 175,009.00 |
| Sep 30, 2022 | 231,559.00 |
| Jun 30, 2022 | 112,237.00 |
| Mar 31, 2022 | 105,135.00 |
| Dec 31, 2021 | -37,407.00 |
| Sep 30, 2021 | 199,757.00 |